We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Misys Plc (MSY.LN), a software products and solutions company announced Monday that subsidiary Allscripts-Misys Healthcare Solutions, Inc. (NASDAQ: MDRX) have commenced the public offering of...
Allscripts Announces Secondary Offering on Behalf of Misys plc PR Newswire CHICAGO, Aug. 15 CHICAGO, Aug. 15 /PRNewswire-FirstCall/ -- Allscripts-Misys Healthcare Solutions, Inc. (Nasdaq: MDRX...
Allscripts and Eclipsys Stockholders Approve Merger PR Newswire CHICAGO and ATLANTA, Aug. 13 CHICAGO and ATLANTA, Aug. 13 /PRNewswire-FirstCall/ -- Allscripts-Misys Healthcare Solutions, Inc...
Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company®, today announced results for the second quarter ended June 30, 2010. Revenues for the quarter ended June 30, 2010...
Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company®, today announced that South Nassau Communities Hospital (South Nassau), a 435-bed teaching hospital located in...
Allscripts Amends Framework Agreement With Misys to Reduce the Size of Planned Secondary Offering Hart-Scott-Rodino Waiting Period Expires PR Newswire CHICAGO, July 27 CHICAGO, July 27...
Allscripts Announces Special Meeting of Stockholders to Vote on Proposed Eclipsys Merger PR Newswire CHICAGO, July 14 CHICAGO, July 14 /PRNewswire-FirstCall/ -- Allscripts-Misys Healthcare...
Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company®, today announced that it will release results for the quarter ended June 30 on Thursday, August 5, 2010. News...
Eclipsys Corporation (NASDAQ:ECLP), The Outcomes Company®, today announced its response to the Center for Medicare and Medicaid Services’(CMS) final rule on ‘meaningful use’ of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions